Anaesthesia
Conditions
Interventions
Dexmedetomidine Group
Sponsors
Al Azhar University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Multiparous women, 21–40 years old. Pregnant woman who received antenatal care. Pregnant woman presented for vaginal delivery of uncomplicated term pregnancy of singleton foetus. Pregnant woman with engaged foetal head and cervical dilatation of at least 4-6 cm requiring oxytocin augmentation, and requested analgesia
Exclusion criteria
Exclusion criteria: Patients with pre-existing or pregnancy-induced hypertension. Abnormal foetal heart rate (FHR) tracings. Obesity, endocrinal diseases and/or diagnosed foetal abnormalities. Contraindication to neuraxial block. Allergy to any of the study drugs and need for intrapartum antiemetic or antispasmodic drugs. Parturient who was at high risk for cesarean section. Refused to participate was excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of intrathecal dexmedetomidine and morphine in reducing pain during and after delivery which assessed by Change on the visual analog scale (VAS) for pain (0 =no pain to 10 = the maximum pain) to assessment the duration of analgesia during and after delivery. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary aim will be to study the complication and adverse effect on the mother and fetus. | — |
Countries
Egypt
Contacts
Public ContactMedhat Fathi
Lecturer of Obstetrics and Gynecology
Outcome results
None listed